Acute serum dynamics extend pregnancy HMO research
Measuring HMOs before and after a routine glucose challenge adds a short-timescale physiological observation to earlier studies of pregnancy metabolic status.
↳ Introduction; Sections 3.2 and 4.1
(1) Background: Pregnancy presents a challenge to maternal glucose homeostasis; suboptimal adaptations can lead to gestational diabetes mellitus (GDM). Human milk oligosaccharides (HMOs) circulate in maternal blood in pregnancy and are altered with GDM, suggesting influence of glucose homeostasis on HMOs. We thus assessed the HMO response to glucose load during an oral glucose tolerance test (OGTT) and investigated HMO associations with glucose tolerance/insulin sensitivity in healthy pregnant women. (2) Methods: Serum of 99 women, collected at 0 h, 1 h and 2 h during a 75 g OGTT at 24-28 gestational weeks was analyzed for HMOs (2'FL, 3'SLN, LDFT, 3'SL) by HPLC; plasma glucose, insulin and C-peptide were analyzed by standard biochemistry methods. (3) Results: Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered. Higher 3'SL at all OGTT time points was associated with a generally more diabetogenic profile, with higher hepatic insulin resistance (HOMA-IR), lower insulin sensitivity (Matsuda index) and higher insulin secretion (C-peptide index 1). (4) Conclusions: Rapid increase in serum 3'SL post-oral glucose load (fasted-fed transition) indicates utilization of plasma glucose, potentially for sialylation of lactose. Associations of sialylated HMOs with a more diabetogenic profile suggest sustained adaptations to impaired glucose homeostasis in pregnancy. Underlying mechanisms or potential consequences of observed HMO changes remain to be elucidated.
Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered.
the repeated time course supports the 3′SL rise, but significant LDFT and 3′SLN changes contradict the unchanged-other-HMOs clause
Higher 3'SL at all OGTT time points was associated with a generally more diabetogenic profile, with higher hepatic insulin resistance (HOMA-IR), lower insulin sensitivity (Matsuda index) and higher insulin secretion (C-peptide index 1).
unadjusted observational correlations leave adiposity confounding unresolved across numerous metabolic comparisons
Rapid increase in serum 3'SL post-oral glucose load (fasted-fed transition) indicates utilization of plasma glucose, potentially for sialylation of lactose.
an uncontrolled concentration time course without mechanistic measurements cannot identify glucose incorporation or lactose sialylation
AUC (0 h to 2 h) of 3′SL and 3′SLN was significantly higher (p = 0.0002 and p = 0.0381, respectively) in Cluster 1 compared to Cluster 2
data-derived clusters without adiposity adjustment or multiplicity control leave the reported comparisons exploratory
Derived from the full evaluation — not a separate score.
Strengths
Measuring HMOs before and after a routine glucose challenge adds a short-timescale physiological observation to earlier studies of pregnancy metabolic status.
↳ Introduction; Sections 3.2 and 4.1
The study samples 99 women at fasting, one hour, and two hours during a standardized OGTT. HPLC standards and internal normalization support comparison of the measured HMO concentrations.
↳ Sections 2.3–2.5 and 3.2
The discussion contrasts acute serum changes with lactation studies suggesting slower dietary effects and identifies missing lactose and sialic acid measurements as barriers to testing the proposed pathway.
↳ Sections 4.1 and 4.4
Limitations
The abstract says HMOs other than 3′SL were unaltered, but Section 3.2 reports an LDFT increase (p = 0.015) and a 3′SLN decrease (p = 0.014). The observed 3′SL rise therefore is not the only reported HMO change.
↳ Abstract, Results; Section 3.2
Metabolic associations rely on unadjusted correlations despite substantial BMI and adiposity differences between clusters, alongside extensive multiple testing. The clusters include 89 of 99 participants, with only one of ten exclusions explained.
↳ Sections 2.7 and 3.3–3.5
The abstract infers glucose utilization for lactose sialylation from an uncontrolled time course. Without direct mechanistic measurements or a time-matched non-glucose control, the concentration rise does not identify the proposed biosynthetic pathway.
↳ Abstract, Conclusions; Sections 2.3, 4.1, and 4.4
Standardized OGTT sampling and internal-standard HPLC provide a focused observation of an acute serum 3′SL rise during mid-pregnancy. The metabolic interpretation is less secure because correlations are unadjusted despite pronounced adiposity differences, and extensive testing makes borderline associations difficult to interpret. Concentration changes alone do not establish the glucose-utilization mechanism asserted in the abstract, even though the discussion acknowledges missing mechanistic measurements. The abstract also incorrectly describes the other HMOs as unchanged, while unexplained cluster exclusions and unit and label errors reduce reporting precision.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Repeated serum HMO measurements during a routine pregnancy OGTT add a focused physiological observation to earlier pregnancy HMO–metabolism associations. The contribution remains descriptive rather than establishing a biosynthetic mechanism.
Standardized repeated sampling, internal-standard HPLC, and metabolic phenotyping support the observed time course, but uncontrolled confounding and mechanistic inference substantially limit interpretation. The abstract–results contradiction and unresolved cluster reporting are separately surfaced in the reliability flag.
The manuscript follows its research questions coherently, but the abstract misstates the specificity of the HMO response. Unit errors, variable mislabelling, and the imprecise AUC description impede checking.
The discussion relates the findings to pregnancy metabolism, sialylation, and contrasting lactation literature while acknowledging absent mechanistic measurements. It does not adequately trace adiposity confounding or unexplained cluster exclusions into the interpretation.
Lower confidence on Contribution, Positioning — domain match limited.
Caveats4 of 4 checks
Ethics approval and written consent are declared. The Results label correlations introduced as 3′SLN correlations with 3′SL identifiers.
Ethics approval: declared
63 of 63 checkable references verified
63 references in manuscript
References not verified automatically are resolved manually within 24 hours.
No retraction or expression of concern found in Crossref (includes Retraction Watch).
Sources: Crossref (incl. Retraction Watch) ✓
The primary claim rests on a single observational cohort of 99 women with within-subject OGTT measurements, with no controlled experiment or independent confirmation.
“Implementation of HMO measurements with the measurements of glucose during an OGTT could be valuable, especially early in pregnancy.”
The paper proposes its HMO findings could serve as biomarkers measured alongside OGTT glucose, but names no actor or setting that would use them.
Clinicians in prenatal care could measure serum 3'SL alongside OGTT glucose as an early biomarker of glucose dysregulation and GDM risk.
Mechanisms and consequences of the HMO changes are unknown, and the small mostly healthy cohort with few GDM cases requires validation in larger independent populations.
Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3
AI-generated, human-governed. Something look off? Contact us to request a review.
Keep reading
Other papers Nabu has evaluated blind, starting with the same field.
Neumann, Mahnert, Kumpitsch, et al. · 2023 · Clinical medicine
We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.
TentativeKurath-Koller, Neumann, Moissl-Eichinger, et al. · 2020 · Clinical medicine
We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.
TentativeBandres-Meriz, Majali-Martinez, Hoch, et al. · 2021 · Clinical medicine
Pregnant women (week 4+0–11+6) with a high C-peptide concentration and low insulin sensitivity (ISHOMA) had decreased serum concentration of total n-3 PUFA
Supported